Leading-Edge Science: Merck and Ridgeback Provide Update

VIP LIVEALERTS-PRO Leading-Edge Science News Leading-Edge Science: Merck and Ridgeback Provide Update on EU Marketing Authorization Application for LAGEVRIO™ (Molnupiravir) RAHWAY, N.J. & MIAMI–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines […]